Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan

被引:37
|
作者
Koike, Teruaki
Tsuchiya, Ryosuke
Goya, Tomoyuki
Sohara, Yasunori
Miyaoka, Etsuo
机构
[1] Niigata Canc Ctr Hosp, Div Chest Surg, Japanese Joint Comm Lung Canc Registrat, Niigata 9518566, Japan
[2] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan
[3] Kyorin Univ, Dept Surg, Mitaka, Tokyo, Japan
[4] Jichi Med Sch, Dept Surg, Minami Kawachi, Tochigi, Japan
[5] Tokyo Univ Sci, Dept Math, Japanese Joint Comm Lung Canc Registrat, Tokyo 162, Japan
关键词
clinical stage I lung cancer; survival; prognostic factor; limited pulmonary resection; maximum tumor diameter;
D O I
10.1097/01.JTO.0000268674.02744.f9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The objective of this retrospective study was to identify prognostic factors in completely resected clinical (c-) stage I non-small cell lung cancer cases. Methods: In 2001, the Japanese Joint Committee of Lung Cancer Registry collected data on the outcome and clinicopathological profiles of 7408 patients who had undergone resection for primary lung cancer in 1994. They included 3315 c-stage I patients who underwent complete resection, and in this study attempted to identify prognostic factors in the c-stage IA and c-stage IB cases. Results: The overall 5-year survival rate was 66.5%: 74.7% in the 2085 c-stage IA cases and 52.5% in the 1230 c-stage IB cases. The survival curve of the c-stage IA cases was higher than that of the c-stage IB cases. Multivariate analysis of the c-stage IA cases revealed six factors that predicted a significantly better outcome: age, gender, pathological (p-) T status, p-N status, nodal dissection, and tumor diameter (: 2 cm), and the same analysis of the c-stage IB cases revealed six factors: age, gender, p-T status, p-N status operative procedure, and tumor diameter (< 5 cm). The c-stage I patients whose tumor diameter was 2 cm or less had a higher survival rate than the patients whose turner diameter was more than 2 cm, and the c-stage IB patients whose tumor diameter was less than 5 cm had a higher survival rate than the patients whose tumor diameter was 5 cm or more. Conclusion: Tumor size is an independent prognostic factor for postoperative survival in c-stage 1 patients.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 50 条
  • [31] HIGHLY EXPRESSED ADAM9 IN COMPLETELY RESECTED STAGE I NON-SMALL CELL LUNG CANCER CASES PREDICTS A SHORTENED SURVIVAL
    Zhang, Jun
    Qi, Juan
    Chen, Ning
    Guo, Yi
    Fu, Weineng
    Zhou, Baosen
    He, Anguang
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1068 - S1069
  • [32] Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
    Jazieh, AR
    Hussain, M
    Howington, JA
    Spencer, HJ
    Husain, M
    Grismer, JT
    Read, RC
    ANNALS OF THORACIC SURGERY, 2000, 70 (04): : 1168 - 1171
  • [33] Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer
    Oshita, Fumihiro
    Morita, Atsushi
    Ito, Hiroyuki
    Kameda, Yoichi
    Tsuchiya, Eiju
    Asai, Shigeru
    Miyagi, Yohei
    ONCOLOGY REPORTS, 2010, 24 (03) : 637 - 645
  • [34] Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
    Hung, J-J
    Hsu, W-H
    Hsieh, C-C
    Huang, B-S
    Huang, M-H
    Liu, J-S
    Wu, Y-C
    THORAX, 2009, 64 (03) : 192 - 196
  • [35] THE PREDICTORS OF EARLY RECURRENCE IN PATIENTS WITH COMPLETELY RESECTED P-STAGE I NON-SMALL CELL LUNG CANCER
    Hata, Kazunori
    Yoshida, Junji
    Ishii, Genichiro
    Hirayama, ShuNKI
    Matsuwaki, Rie
    Matsumura, Yuki
    Aokage, Keiju
    Hishida, Tomoyuki
    Nagai, Kanji
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S623 - S623
  • [36] Risk Factors for Recurrence According to Site in Resected Stage I Non-Small Cell Lung Cancer
    Shiono, S.
    Endo, M.
    Nakahashi, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S986 - S987
  • [37] Prognostic markers for stage I non-small cell lung cancer
    Ohara, Gen
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    LUNG CANCER, 2008, 59 (01) : 137 - 137
  • [38] Prognostic indicators in stage I non-small cell lung cancer
    Barlési, F
    Doddoli, C
    Greillier, L
    Astoul, P
    Giudicelli, R
    Fuentes, P
    Thomas, P
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 93 - 103
  • [39] A clinical model to estimate recurrence rusk in resected stage I non-small cell lung cancer
    Goodgame, Boone
    Hiswanathan, Avinash
    Miller, Ryan
    Gao, Feng
    Meyers, Bryan
    Battafarano, Richard J.
    Patterson, Alexander
    Cooper, Joel
    Guthrie, Tracey J.
    Bradley, Jeffrey
    Pillot, Giancarlo
    Govindan, Ramaswamy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 22 - 28
  • [40] Prognostic value of preoperative plasma fibrinogen levels in resected stage I non-small cell lung cancer
    Mitsui, Suguru
    Tanaka, Yugo
    Doi, Takefumi
    Hokka, Daisuke
    Maniwa, Yoshimasa
    THORACIC CANCER, 2022, 13 (10) : 1490 - 1495